Categorie > Epilepsy

Drama Or Reality TV: Do Medical Shows Depict Proper First Aid For Seizures?

Categorie : Epilepsy
Watching TV medical shows might not be the best way to learn what to do when someone has a seizure... ...

read more Watching TV medical shows might not be the best way to learn what to do when someone has a seizure... read more Fri Mar 2010

Health Minister Calls For Regional Epilepsy Champions In Health Trusts

Categorie : Epilepsy
Health minister Ann Keen MP has today called for primary care trusts and strategic health authorities to "identify an epilepsy champion who can drive a local review of epilepsy services and put in place an implementation plan to commission world-class epilepsy services"... ...

read more Health minister Ann Keen MP has today called for primary care trusts and strategic health authorities to read more Fri Mar 2010

Scientists Discover Clues To Human Diseases By Studying Dolphins In A Changing Ocean

Categorie : Epilepsy
A panel of governmental, academic and non-profit scientists speaking at the annual meeting of the American Association for the Advancement of Science (AAAS) unveiled research suggesting that diseases found in dolphins are similar to human diseases and can provide clues into how human health might be ...

read more A panel of governmental, academic and non-profit scientists speaking at the annual meeting of the American Association for the Advancement of Science (AAAS) unveiled research suggesting that diseases found in dolphins are similar to human diseases and can provide clues into how human health might be read more Fri Mar 2010

High-Fat Ketogenic Diet To Control Seizures Is Safe Over Long Term

Categorie : Epilepsy
Current and former patients treated with the high-fat ketogenic diet to control multiple, daily and severe seizures can be reassured by the news that not only is the diet effective, but it also appears to have no long-lasting side effects, say scientists at Johns Hopkins Children's Center... ...

read more Current and former patients treated with the high-fat ketogenic diet to control multiple, daily and severe seizures can be reassured by the news that not only is the diet effective, but it also appears to have no long-lasting side effects, say scientists at Johns Hopkins Children's Center... read more Fri Mar 2010

First Aid For Seizures Portrayed Inaccurately On Popular TV Dramas

Categorie : Epilepsy
New research from Canada shows that almost half of the time, doctors and nurses on popular TV medical dramas respond inappropriately to seizures, suggesting that watching TV is not the best way to learn what to do if you are present when someone has a seizure... ...

read more New research from Canada shows that almost half of the time, doctors and nurses on popular TV medical dramas respond inappropriately to seizures, suggesting that watching TV is not the best way to learn what to do if you are present when someone has a seizure... read more Fri Mar 2010

Mayo Clinic Designated Top Epilepsy Treatment Center

Categorie : Epilepsy
Mayo Clinic has been designated a comprehensive epilepsy treatment center by the National Association of Epilepsy Centers (NAEC). Only the top epilepsy programs - those that can provide the most complex and advanced care - are selected for this designation, according to the association... ...

read more Mayo Clinic has been designated a comprehensive epilepsy treatment center by the National Association of Epilepsy Centers (NAEC). Only the top epilepsy programs - those that can provide the most complex and advanced care - are selected for this designation, according to the association... read more Fri Mar 2010

Lacosamide Validated As Promising Therapy For Uncontrolled Partial-Onset Seizures

Categorie : Epilepsy
A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizures (POS), and doses of 600mg/day may provide additional benefit for some patients. Researchers from th ...

read more A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizures (POS), and doses of 600mg/day may provide additional benefit for some patients. Researchers from th read more Fri Mar 2010

Neural Mechanism May Underlie An Enhanced Memory For The Unexpected

Categorie : Epilepsy
The human brain excels at using past experiences to make predictions about the future. However, the world around us is constantly changing, and new events often violate our logical expectations. "We know these unexpected events are more likely to be remembered than predictable events, but the underl ...

read more The human brain excels at using past experiences to make predictions about the future. However, the world around us is constantly changing, and new events often violate our logical expectations. read more Fri Mar 2010

Non-invasive Testing, Earlier Surgery Can Stop Seizures In Tuberous Sclerosis Complex

Categorie : Epilepsy
When medication fails to control seizures in children with tuberous sclerosis complex (TSC), a rare genetic disorder that affects multiple organ systems and frequently causes epilepsy, surgery to remove part of the brain is often necessary. But pre-surgical testing, which involves the implanting of ...

read more When medication fails to control seizures in children with tuberous sclerosis complex (TSC), a rare genetic disorder that affects multiple organ systems and frequently causes epilepsy, surgery to remove part of the brain is often necessary. But pre-surgical testing, which involves the implanting of read more Wed Feb 2010

FDA Approves Once-A-Day Lamictal(R)XR(TM) As Add-On Epilepsy Therapy For Primary Generalized Tonic-Clonic Seizures

Categorie : Epilepsy
GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration has approved Lamictal®XR™ (lamotrigine) Extended-Release Tablets as once-a-day, add-on therapy for epilepsy in patients ages 13 years and older with primary generalized tonic-clonic seizures... ...

read more GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration has approved Lamictal®XR™ (lamotrigine) Extended-Release Tablets as once-a-day, add-on therapy for epilepsy in patients ages 13 years and older with primary generalized tonic-clonic seizures... read more Wed Feb 2010

Government Cracks Down On Drug Marketing

Categorie : Epilepsy
Recent crackdown on pharmaceutical companies suggests that drug marketing remains an issue with federal authorities. The Wall Street Journal reports: "Novartis AG's agreement to settle criminal allegations involving marketing of an epilepsy drug is the latest in a string of cases showing that impro ...

read more Recent crackdown on pharmaceutical companies suggests that drug marketing remains an issue with federal authorities. The Wall Street Journal reports: read more Wed Feb 2010

FDA Extends PDUFA Action Date For STEDESA™ New Drug Application

Categorie : Epilepsy
Sepracor Inc. announced that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency now anticipates completing its review of the STEDESA™ (eslicarbazepine acetate) New Drug Application (NDA) on April 30, 2010, which is a three-month extension to the original ...

read more Sepracor Inc. announced that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency now anticipates completing its review of the STEDESA™ (eslicarbazepine acetate) New Drug Application (NDA) on April 30, 2010, which is a three-month extension to the original read more Thu Jan 2010

New Tools Use Light To Turn Off Brain Cells And Possibly Treat Brain Disorders

Categorie : Epilepsy
Neuroscientists at the Massachusetts Institute of Technology have developed a powerful new class of tools to reversibly shut down brain activity using different colors of light. When targeted to specific neurons, they could potentially lead to new treatments for abnormal brain activity associated wi ...

read more Neuroscientists at the Massachusetts Institute of Technology have developed a powerful new class of tools to reversibly shut down brain activity using different colors of light. When targeted to specific neurons, they could potentially lead to new treatments for abnormal brain activity associated wi read more Mon Jan 2010

UV LED Therapy Shows Promising Results In Preventing Focal Seizures

Categorie : Epilepsy
Researchers from the University of Minnesota Medical School discovered that light from an ultraviolet diode (UV LED) reduced "seizure-like" activity in a rat epilepsy model. During the study, UV light released gamma aminobutyric acid (GABA) from the "caged" compound carbonyl amino butanoic acid (BC2 ...

read more Researchers from the University of Minnesota Medical School discovered that light from an ultraviolet diode (UV LED) reduced read more Mon Jan 2010

Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches And Increased Seizure Activity

Categorie : Epilepsy
Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced results of a study that examined the association of seizure risk among epilepsy patients after switching between A-rated anti-epileptic drug formulations... ...

read more Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced results of a study that examined the association of seizure risk among epilepsy patients after switching between A-rated anti-epileptic drug formulations... read more Thu Dec 2009

Pivotal Trial Data Demonstrate Neuropace RNS System Reduced Seizures In People With Epilepsy

Categorie : Epilepsy
NeuroPace, Inc. has announced that results from its pivotal trial demonstrated the RNS® System, a novel investigational device that utilizes responsive brain neurostimulation, significantly reduced the frequency of seizures among people who have a common form of epilepsy that is difficult to treat ...

read more NeuroPace, Inc. has announced that results from its pivotal trial demonstrated the RNS® System, a novel investigational device that utilizes responsive brain neurostimulation, significantly reduced the frequency of seizures among people who have a common form of epilepsy that is difficult to treat read more Sat Dec 2009

Research Breaks New Ground For People With Epilepsy

Categorie : Epilepsy
Pioneering research undertaken at the University of Sheffield has revealed that linguistic observations can help doctors differentiate between two of the most common causes of blackouts. The news comes within National Epilepsy Month, which aims to raise awareness about epilepsy and promote toleranc ...

read more Pioneering research undertaken at the University of Sheffield has revealed that linguistic observations can help doctors differentiate between two of the most common causes of blackouts. The news comes within National Epilepsy Month, which aims to raise awareness about epilepsy and promote toleranc read more Wed Dec 2009

Brain Waves Can 'Write' On A Computer In Early Tests - Shown By Mayo Clinic Researchers

Categorie : Epilepsy
Neuroscientists at the Mayo Clinic campus in Jacksonville, Fla., have demonstrated how brain waves can be used to type alphanumerical characters on a computer screen. By merely focusing on the "q" in a matrix of letters, for example, that "q" appears on the monitor... ...

read more Neuroscientists at the Mayo Clinic campus in Jacksonville, Fla., have demonstrated how brain waves can be used to type alphanumerical characters on a computer screen. By merely focusing on the read more Wed Dec 2009

Epilepsy Patients Caught In Treatment Gap And Not Getting State-of-the-Art Care

Categorie : Epilepsy
Substantial progress has been made over the last 15 years in the healthcare community's ability to diagnose and treat epilepsy and its complications. Yet this progress in epilepsy management has not reached most of the 50 million people around the world, including many of the nearly three million pe ...

read more Substantial progress has been made over the last 15 years in the healthcare community's ability to diagnose and treat epilepsy and its complications. Yet this progress in epilepsy management has not reached most of the 50 million people around the world, including many of the nearly three million pe read more Wed Dec 2009

NYU Langone Medical Center Study Shows VNS Therapy Is A Safe And Effective Treatment For Refractory Epilepsy

Categorie : Epilepsy
AES Annual Meeting, Booth #901-- Cyberonics, Inc. (Nasdaq: CYBX) announced that Vagus Nerve Stimulation (VNS) Therapy, the only FDA-approved implantable medical device for the treatment of refractory epilepsy, will be featured in 14 presentations at the American Epilepsy Society's (AES) Annual Meeti ...

$read more AES Annual Meeting, Booth #901-- Cyberonics, Inc. (Nasdaq: CYBX) announced that Vagus Nerve Stimulation (VNS) Therapy, the only FDA-approved implantable medical device for the treatment of refractory epilepsy, will be featured in 14 presentations at the American Epilepsy Society's (AES) Annual Meeti$ read more Wed Dec 2009

1 | 2 | 3 | 4 next >>>

eHealth Guide News Abortion ADHD Aid / Disasters Alcohol / Addiction Allergy Alzheimer's Anxiety Arthritis Asthma / Respiratory Autism Bio-terrorism / Terrorism Biology / Biochemistry Bipolar Bird Flu / Avian Flu Blood / Hematology Body Aches Bones / Orthopaedics Breast Cancer Cancer / Oncology Cardiovascular / Cardiology Caregivers / Homecare Cholesterol CJD / vCJD / Mad Cow Disease Cleft Palate Clinical Trials / Drug Trials Colorectal Cancer Complementary Medicine / Alternative Medicine Compliance Conferences Cosmetic Medicine / Plastic Surgery Crohn's Cystic Fibrosis Dentistry Depression Dermatology Diabetes Dyslexia Ear, Nose and Throat Endocrinology Epilepsy Erectile Dysfunction / Premature Ejaculation Eye Health / Optometry Fertility Flu / SARS GastroIntestinal Genetics Gout Headache / Migraine Health Insurance / Medical Insurance Hearing / Deafness HIV / AIDS Huntingtons Disease Hypertension Immune System / Vaccines Infectious Diseases / Bacteria / Viruses Irritable-Bowel Syndrome Liver Disease / Hepatitis Lung Cancer Lupus Lymphoma / Leukemia Medical Devices Medical Malpractice / Litigation Medical Students Medicare / Medicaid / Tricare Men's health Mental Health MRI / PET / Ultrasound MRSA / Drug Resistance Multiple Sclerosis Muscular Dystrophy Neurology / Neuroscience Nursing Nutrition/Agriculture Obesity / Weight Loss / Fitness Pain / Anesthetics Parkinson's Disease Pediatrics Pharma Industry Pregnancy Primary Care / General Practice Prostate Psychology / Psychiatry Public Health Radiology / Nuclear Medicine Rehabilitation Schizophrenia Seniors / Aging Sexual Health / STDs Sleep / Sleep Disorders Smoking / Quit Smoking Sports Medicine / Fitness Statins Stem Cell Research Stroke / Neuroprotection Transplants / Organ Donations Tropical Diseases Urology / Nephrology Veterinary Water Quality / Air Quality Women's Health / OBGYN Health Policy Health Jobs Listing